View full meeting coverage »

Eyetube Meeting Coverage:

2018 ARVO Annual Meeting

 

Editorially Independent Content, Financially Supported by

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Quarterly Dosing and AMD: A Cross-Trial Comparison

  Channels: Retina | Posted 5/3/2018

David Eichenbaum, MD, summarizes his ARVO presentation, which took a retrospective look at a number of pivotal trials in which patients received intravitreal anti-VEGF injections at quarterly intervals. He explains how patients do with this regimen, and talks about being able to detect and predict which patients can tolerate less frequent dosing.

AMD • Anti-VEGF • Intravitreal Injection


12 / 13 Series: 2018 ARVO Annual Meeting